B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ANO1

MOLECULAR TARGET

anoctamin 1, calcium activated chloride channel

UniProt: Q8BHY3NCBI Gene: 10177217 compounds

ANO1 (anoctamin 1, calcium activated chloride channel) is targeted by 17 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ANO1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Calcimycin1.102
2Hexachlorophene1.102
3Niclosamide1.102
4rafoxanide1.102
5Bisphenol A-Glycidyl Methacrylate0.691
6Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of0.691
7Calcitriol0.691
8Cefazolin0.691
9Desoxycorticosterone Acetate0.691
10Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
11Loratadine0.691
12Melengestrol Acetate0.691
13Methimazole0.691
14Nialamide0.691
15Masoprocol0.691
16Thioridazine0.691
17tyrphostin 90.691

About ANO1 as a Drug Target

ANO1 (anoctamin 1, calcium activated chloride channel) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 17 compounds with documented ANO1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ANO1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.